Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:354-359

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rocchini, A. P.
Right arrow Articles by Cervenka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rocchini, A. P.
Right arrow Articles by Cervenka, T.

(Hypertension. 1996;27:354-359.)
© 1996 American Heart Association, Inc.


Articles

Metabolic and Hemodynamic Effects of a Graded Intracoronary Insulin Infusion in Normal and Fat Anesthetized Dogs

A Preliminary Study

Albert P. Rocchini; Robert F. Wilson; Paul Marker; Tereza Cervenka

From the Divisions of Pediatric Cardiology and Adult Cardiology, Departments of Pediatrics and Internal Medicine, University of Minnesota, Minneapolis.

Abstract This study evaluated both cardiac hemodynamic and metabolic effects of a graded intracoronary artery infusion of insulin in four normal and five obese anesthetized dogs. Dogs were anesthetized with isoflurane, a catheter was advanced under fluoroscopic guidance into the coronary sinus and great cardiac vein, and a 20-MHz 3F coronary Doppler catheter was advanced into either the mid left anterior descending or circumflex coronary artery. A graded intracoronary insulin infusion was administered (starting at 0.3 mU/min and doubling every 40 minutes until a maximum dose of 2.4 mU/min was achieved). Coronary glucose extraction, coronary blood flow velocity, and coronary artery size were measured at each infusion rate. An intracoronary artery infusion of insulin stimulated myocardial glucose uptake in normal dogs. However, in high-fat–fed dogs, weight gain was associated with a reduction in the ability of insulin to promote glucose uptake by cardiac muscle and a rightward shift in the dose-response curve. In normal dogs, an intracoronary insulin infusion resulted in an increase in coronary blood flow and coronary vasodilation (with insulin coronary vascular resistance index decreases to 0.72±0.06, P<.01), whereas with weight gain the vasodilator response to insulin was lost. The loss of coronary artery vasodilation to local hyperinsulinemia in fat-fed dogs is consistent with other reports in obese or hypertensive humans that document an impairment in the action of insulin to increase skeletal muscle blood flow.


Key Words: obesity • insulin resistance • coronary blood flow • myocardial metabolism




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. A Nikolaidis, A. Sturzu, C. Stolarski, D. Elahi, Y.-T. Shen, and R. P Shannon
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
Cardiovasc Res, February 1, 2004; 61(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Sundell and J. Knuuti
Insulin and myocardial blood flow
Cardiovasc Res, February 1, 2003; 57(2): 312 - 319.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Jagasia, J. M. Whiting, J. Concato, S. Pfau, and P. H. McNulty
Effect of Non-Insulin-Dependent Diabetes Mellitus on Myocardial Insulin Responsiveness in Patients With Ischemic Heart Disease
Circulation, April 3, 2001; 103(13): 1734 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D. J. Betteridge, E. Ferrannini, and P. G. Camici
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1163 - E1171.
[Abstract] [Full Text] [PDF]